Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Molgramostim for NTM in Cystic Fibrosis (ENCORE)
NCT03597347Phase 2Terminated
- Sponsor
- Savara
- Start
- Jun 2019
- Primary completion
- Oct 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of molgramostim in nontuberculous mycobacteria infection, sponsored by Savara. Started Jun 2019; status: terminated.
02
Drugs
molgramostim
03
Conditions
nontuberculous mycobacteria infection
Beyond the preview
Go deeper on NCT03597347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597347.